The Efficacy of Non-Pharmacological Interventions for Sleep Disorders in People With Multiple Sclerosis: a Systematic Review and Meta-Analysis

dc.contributor.author Ozdogar, Asiye Tuba
dc.contributor.author Kalron, Alon
dc.date.accessioned 2025-06-01T20:06:53Z
dc.date.available 2025-06-01T20:06:53Z
dc.date.issued 2025
dc.description.abstract Sleep disorders significantly impact the quality of life in people with multiple sclerosis (pwMS), affecting up to 60% of this population. These disorders, including insomnia, sleep apnea, restless legs syndrome, narcolepsy, and REM sleep behaviour disorders, result from both the direct neurological impacts of MS and secondary factors, such as pain and medication side effects. Non-pharmacological interventions offer potential benefits without the adverse effects associated with medications. This systematic review and meta-analysis aimed to evaluate the efficacy of non-pharmacological interventions in improving sleep disorders in pwMS, address inconsistencies in individual studies, and provide estimates of the magnitude of improvement. The review followed PRISMA guidelines and included randomised controlled trials, even if pilot studies, that examined non-pharmacological interventions for sleep disorders in pwMS. The literature search was completed in April 2024 in PubMed, Embase, and Web of Science databases. Data were extracted on study design, participant characteristics, intervention details, and outcomes. Quality was assessed using the PEDro scale, and a random-effects meta-analysis was conducted. The primary outcome was the assessment of sleep quality. Nine studies met the inclusion criteria, encompassing various non-pharmacological interventions such as cognitive-behavioural therapy, mindfulness, aerobic exercise, and occupational therapy. Non-pharmacological interventions may effectively improve sleep disorders in pwMS, while also providing additional benefits for overall psychological well-being and quality of life. Future research should focus on long-term effects, underlying mechanisms, and standardising intervention protocols to enhance comparability and generalisability. The major limitation of the meta-analysis is the high heterogeneity among eligible studies. en_US
dc.identifier.doi 10.1111/jsr.70084
dc.identifier.issn 0962-1105
dc.identifier.issn 1365-2869
dc.identifier.scopus 2-s2.0-105004282010
dc.identifier.uri https://doi.org/10.1111/jsr.70084
dc.identifier.uri https://hdl.handle.net/20.500.14720/25035
dc.language.iso en en_US
dc.publisher Wiley en_US
dc.rights info:eu-repo/semantics/closedAccess en_US
dc.subject Cbt en_US
dc.subject Multiple Sclerosis en_US
dc.subject Non-Pharmacological en_US
dc.subject Sleep Disorders en_US
dc.title The Efficacy of Non-Pharmacological Interventions for Sleep Disorders in People With Multiple Sclerosis: a Systematic Review and Meta-Analysis en_US
dc.type Article en_US
dspace.entity.type Publication
gdc.author.scopusid 57197818415
gdc.author.scopusid 24504227700
gdc.author.wosid Kalron, Alon/Aat-2960-2021
gdc.author.wosid Özdoğar, Asiye Tuba/Aar-7623-2020
gdc.coar.access metadata only access
gdc.coar.type text::journal::journal article
gdc.description.department T.C. Van Yüzüncü Yıl Üniversitesi en_US
gdc.description.departmenttemp [Ozdogar, Asiye Tuba] Van Yuzuncu Yil Univ, Fac Hlth Sci, Dept Physiotherapy, TR-65080 Van, Turkiye; [Kalron, Alon] Tel Aviv Univ, Fac Med & Hlth Sci, Sch Hlth Profess, Dept Phys Therapy, Tel Aviv, Israel; [Kalron, Alon] Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv, Israel; [Kalron, Alon] Sheba Med Ctr, Multiple Sclerosis Ctr, Tel Hashomer, Israel en_US
gdc.description.publicationcategory Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı en_US
gdc.description.scopusquality Q1
gdc.description.woscitationindex Science Citation Index Expanded
gdc.description.wosquality Q2
gdc.identifier.pmid 40325863
gdc.identifier.wos WOS:001481714900001
gdc.index.type WoS
gdc.index.type Scopus
gdc.index.type PubMed

Files